outpatient therapy.

COVID-19 Trial to Combat Delta Variant

UT Health Science Center at Houston, Baylor College of Medicine and Johns Hopkins University are enrolling for two new Covid-19 treatment and prevention studies in the Houston metro area. If you have recently been diagnosed with COVID-19, you may be eligible, and participants will be compensated up to $575. This is the first U.S. multi-center, double-blind, randomized clinical trial to assess the effectiveness of convalescent blood plasma as an outpatient therapy. Antibodies are one of […]